[{"Assets_0_Q2_USD":266817668.0,"CommonStockSharesOutstanding_0_Q2_shares":56154438.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-53630126.0,"NetIncomeLoss_1_Q2_USD":-33334300.0,"NetIncomeLoss_2_Q2_USD":-55070606.0,"StockholdersEquity_0_Q2_USD":229552106.0,"Ticker":"APLS","CIK":"1492422","name":"APELLIS PHARMACEUTICALS, INC.","OfficialName":"Apellis Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"5553923312.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180731"}]